In recent years, the application of nanotechnology in AAT has demonstrated immense potential, with tumour‐targeted nanodrug delivery systems gaining significant attention in cancer treatment because of their tumour specificity, efficient drug delivery and resistance to drug resistance mechanisms.206. Here, SERPINA1 is linked to neoplasm.